Written by Mark O'Neill
Grief and depression feel similar, but they’re not the same. Learn how to tell them apart, recognize when grief becomes prolonged, and find the right kind of support for real recovery.
Written by Mark O'Neill
Switching between different generic medications is common but can be risky for certain drugs like thyroid medication or blood thinners. Learn which generics are safe to switch and how to protect yourself from dangerous changes.
Written by Mark O'Neill
Learn how to create a personalized Medication Action Plan with your care team to improve adherence, avoid dangerous interactions, and take control of your daily medication routine. Step-by-step guide for patients on multiple prescriptions.
Written by Mark O'Neill
Global drug safety monitoring is becoming more aligned through ICH guidelines, AI tools, and shared data systems. Learn how harmonized pharmacovigilance reduces delays, cuts costs, and saves lives - and where gaps still remain.
Written by Mark O'Neill
Probiotics can be dangerous for people on immunosuppressants, risking life-threatening infections. Learn who’s at risk, which strains to avoid, and what safer alternatives exist.
Written by Mark O'Neill
NTI drugs have a tiny margin between safe and toxic doses. Common examples include warfarin, lithium, digoxin, and tacrolimus. Even small changes in dose or brand can cause serious harm. Regular blood tests and strict adherence are critical for safety.
Written by Mark O'Neill
OCT, fundus photography, and fluorescein angiography are essential tools for diagnosing eye diseases. Learn how each works, what they show, and why doctors use them together to protect your vision.
Written by Mark O'Neill
Steroid use can cause dangerous blood sugar spikes in people with or without diabetes. Learn how to adjust insulin doses, monitor glucose effectively, and avoid hypoglycemia during steroid tapering with evidence-based strategies.
Written by Mark O'Neill
Chemotherapy drug interactions can be life-threatening. Learn which medications, supplements, and foods interfere with cancer treatment, who's at risk, and how to stay safe during therapy.
Written by Mark O'Neill
Alpha-1 antitrypsin deficiency is a genetic cause of early-onset COPD and liver disease. Learn how it differs from smoking-related COPD, how it's diagnosed, and what treatments like augmentation therapy can do-plus what’s coming next.